project id: TCGA-PAAD; case submitter id: TCGA-IB-AAUQ; no matched normal low pass wgs: false; no matched normal targeted sequencing: false; no matched normal wgs: false; no matched normal wxs: false; selected normal low pass wgs: false; selected normal targeted sequencing: false; selected normal wxs: false; source center: 23; state: released; a260 a280 ratio: 1.88; normal tumor genotype snp match: Yes; ribosomal rna 28s 16s ratio: 1.13; rna integrity number: 7.1; age at index: 50; days to birth: -18315; days to death: 183; ethnicity: not hispanic or latino; gender: male; race: white; vital status: Dead; year of birth: 1963; year of death: 2013; age at diagnosis: 18315; ajcc pathologic m: M0; ajcc pathologic n: N1; ajcc pathologic stage: Stage IIB; ajcc pathologic t: T3; ajcc staging system edition: 7th; classification of tumor: not reported; days to diagnosis: 0; icd 10 code: C25.2; last known disease status: not reported; morphology: 8500/3; primary diagnosis: Infiltrating duct carcinoma, NOS; prior malignancy: no; prior treatment: No; progression or recurrence: not reported; site of resection or biopsy: Tail of pancreas; synchronous malignancy: No; tissue or organ of origin: Tail of pancreas; tumor grade: Not Reported; year of diagnosis: 2013; alcohol history: Yes; cigarettes per day: 3.780821917808219; pack years smoked: 69.0; years smoked: 23.0; is ffpe: false; composition: Not Reported; days to collection: 79; days to sample procurement: 0; initial weight: 240.0; portion submitter id: TCGA-IB-AAUQ-01A-22; percent lymphocyte infiltration: 40.0; percent monocyte infiltration: 20.0; percent necrosis: 20.0; percent neutrophil infiltration: 20.0; percent normal cells: 0.0; percent stromal cells: 40.0; percent tumor cells: 40.0; percent tumor nuclei: 40.0;